Published in Cancer on April 01, 2010
Influence of patient, physician, and hospital factors on 30-day readmission following pancreatoduodenectomy in the United States. JAMA Surg (2013) 2.03
Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy. J Am Coll Surg (2011) 1.64
Costs and trends in pancreatic cancer treatment. Cancer (2012) 1.04
Surgical therapy for early hepatocellular carcinoma in the modern era: a 10-year SEER-medicare analysis. Ann Surg (2013) 1.04
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer. Ann Surg Oncol (2014) 0.94
Impact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data base. Ann Surg Oncol (2013) 0.92
Pulmonary metastases in pancreatic cancer, is there a survival influence? J Gastrointest Oncol (2015) 0.87
Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma. Surgery (2014) 0.86
Time trends in the treatment and prognosis of resectable pancreatic cancer in a large tertiary referral centre. HPB (Oxford) (2013) 0.81
Trends in Receipt and Timing of Multimodality Therapy in Early-Stage Pancreatic Cancer. J Gastrointest Surg (2015) 0.80
Neoadjuvant treatment for resectable pancreatic adenocarcinoma. World J Clin Oncol (2016) 0.77
Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach. Ann Surg Oncol (2016) 0.75
CT Imaging Biomarkers Predict Clinical Outcomes After Pancreatic Cancer Surgery. Medicine (Baltimore) (2016) 0.75
Health care costs in the last week of life: associations with end-of-life conversations. Arch Intern Med (2009) 6.46
Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol (2009) 4.39
Does reimbursement influence chemotherapy treatment for cancer patients? Health Aff (Millwood) (2006) 4.33
Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ (2004) 4.13
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg (2007) 4.09
Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst (2006) 4.01
Clinical analyses of clustered microcalcifications after autologous fat injection for breast augmentation. Plast Reconstr Surg (2011) 3.96
Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors. J Clin Oncol (2012) 3.36
Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med (2008) 3.29
How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatment. Health Aff (Millwood) (2010) 3.24
Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg (2003) 3.13
Preventive care for colorectal cancer survivors: a 5-year longitudinal study. J Clin Oncol (2008) 2.68
Trends in follow-up and preventive care for colorectal cancer survivors. J Gen Intern Med (2008) 2.64
Solubility trapping in formation water as dominant CO(2) sink in natural gas fields. Nature (2009) 2.57
Association of hospital spending intensity with mortality and readmission rates in Ontario hospitals. JAMA (2012) 2.47
C. elegans Dynamin mediates the signaling of phagocytic receptor CED-1 for the engulfment and degradation of apoptotic cells. Dev Cell (2006) 2.41
Comparing care for breast cancer survivors to non-cancer controls: a five-year longitudinal study. J Gen Intern Med (2009) 2.36
Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344). J Natl Cancer Inst (2006) 2.34
Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Ann Intern Med (2011) 2.34
Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol (2011) 2.31
New direction in PACS education and training. Comput Med Imaging Graph (2003) 2.29
Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer (2003) 2.26
Perioperative mortality for pancreatectomy: a national perspective. Ann Surg (2007) 2.26
Prevention, screening, and surveillance care for breast cancer survivors compared with controls: changes from 1998 to 2002. J Clin Oncol (2009) 2.26
The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr (2010) 2.25
The effect of race on invasive staging and surgery in non-small-cell lung cancer. J Clin Oncol (2005) 2.21
Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl (2011) 2.10
End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08
Measuring complications of cancer treatment using the SEER-Medicare data. Med Care (2002) 2.05
Pancreatic neuroendocrine tumors: the impact of surgical resection on survival. Cancer (2009) 2.01
End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector. Cancer (2010) 2.01
Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med (2013) 2.00
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95
The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med (2002) 1.90
A protein folding pathway with multiple folding intermediates at atomic resolution. Proc Natl Acad Sci U S A (2005) 1.82
Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77
Looking back from death: the value of retrospective studies of end-of-life care. J Clin Oncol (2006) 1.75
Racial and ethnic differences in end-of-life care in fee-for-service Medicare beneficiaries with advanced cancer. J Am Geriatr Soc (2008) 1.74
Admission volume determines outcome for patients with acute pancreatitis. Gastroenterology (2009) 1.73
Breast cancer survivors' perceptions of survivorship care options. J Clin Oncol (2011) 1.72
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
Surgical management of acute cholecystitis at a tertiary care center in the modern era. Arch Surg (2010) 1.70
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin. Nature (2012) 1.69
Phagocytic receptor CED-1 initiates a signaling pathway for degrading engulfed apoptotic cells. PLoS Biol (2008) 1.68
Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation (2008) 1.68
The effect on survival of continuing chemotherapy to near death. BMC Palliat Care (2011) 1.66
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer. J Clin Oncol (2006) 1.64
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63
Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood (2010) 1.63
Hospital characteristics, clinical severity, and outcomes for surgical oncology patients. Surgery (2010) 1.62
15N NMR spin relaxation dispersion study of the molecular crowding effects on protein folding under native conditions. J Am Chem Soc (2006) 1.60
Towards using administrative databases to measure population-based indicators of quality of end-of-life care: testing the methodology. Palliat Med (2006) 1.60
Two PI 3-kinases and one PI 3-phosphatase together establish the cyclic waves of phagosomal PtdIns(3)P critical for the degradation of apoptotic cells. PLoS Biol (2012) 1.57
Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database. World J Surg (2011) 1.57
Glial precursors clear sensory neuron corpses during development via Jedi-1, an engulfment receptor. Nat Neurosci (2009) 1.54
Tetraalkylammonium amino acids as functionalized ionic liquids of low viscosity. Chem Commun (Camb) (2007) 1.51
Colectomy performance improvement within NSQIP 2005-2008. J Surg Res (2011) 1.50
Complications after pancreatectomy for neuroendocrine tumors: a national study. J Surg Res (2010) 1.49
Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value Health (2008) 1.48
Hospital volume as a surrogate for laparoscopically assisted colectomy. Surg Endosc (2009) 1.48
Lower use of hospice by cancer patients who live in minority versus white areas. J Gen Intern Med (2007) 1.47
Colorectal neoplasia screening before age 50?: current epidemiologic trends in the United States. Dis Colon Rectum (2009) 1.47
Behavioral health services for women who have breast cancer. J Clin Oncol (2008) 1.45
Trends in atrial fibrillation complicating acute myocardial infarction. Am J Cardiol (2009) 1.45
Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol (2005) 1.44
Readmission After Resections of the Colon and Rectum: Predictors of a Costly and Common Outcome. Dis Colon Rectum (2015) 1.41
Outcomes in octogenarians with subdural hematomas. Clin Neurol Neurosurg (2013) 1.41
Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness. J Clin Oncol (2003) 1.41
Cooperation between engulfment receptors: the case of ABCA1 and MEGF10. PLoS One (2006) 1.41
Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis. BMC Cancer (2009) 1.40
Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol (2006) 1.39
Advancing performance measurement in oncology: quality oncology practice initiative participation and quality outcomes. J Oncol Pract (2011) 1.38
Clearance of apoptotic cells in Caenorhabditis elegans. Semin Cell Dev Biol (2005) 1.38
Preventive care in prostate cancer patients: following diagnosis and for five-year survivors. J Cancer Surviv (2011) 1.38
A HIPAA-compliant architecture for securing clinical images. J Digit Imaging (2006) 1.37
Racial segregation and disparities in cancer stage for seniors. J Gen Intern Med (2008) 1.36
Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg (2009) 1.34
Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer. Dis Colon Rectum (2009) 1.33
Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data. Clin Gastroenterol Hepatol (2008) 1.33
Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls. J Clin Oncol (2013) 1.32
How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer? Cancer (2010) 1.30
Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol (2007) 1.29
Racial segregation and disparities in breast cancer care and mortality. Cancer (2008) 1.28
Dipolar coupling between nitroxide spin labels: the development and application of a tether-in-a-cone model. Biophys J (2005) 1.26
Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys (2006) 1.25
Distinct functions of the ubiquitin-proteasome pathway influence nucleotide excision repair. EMBO J (2006) 1.24
The small GTPase Rab2 functions in the removal of apoptotic cells in Caenorhabditis elegans. J Cell Biol (2008) 1.23
Associations among cancer survivorship discussions, patient and physician expectations, and receipt of follow-up care. J Clin Oncol (2010) 1.23
Two alternative mechanisms that regulate the presentation of apoptotic cell engulfment signal in Caenorhabditis elegans. Mol Biol Cell (2007) 1.23
The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data. Arch Otolaryngol Head Neck Surg (2004) 1.22
Hospice care and survival among elderly patients with lung cancer. J Palliat Med (2011) 1.22